Cadila Healthcare informs about press release

01 Mar 2016 Evaluate

Cadila Healthcare has informed about a Press Release dated March 01, 2016 titled ‘Zydus receives final approval from the USFDA for Glyburide and Metformin Hcl Tablets USP’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

903.15 -13.40 (-1.46%)
13-Mar-2026 12:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.05
Dr. Reddys Lab 1286.20
Cipla 1305.40
Zydus Lifesciences 903.15
Lupin 2323.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×